Hypercholesterolemia
Pipeline by Development Stage
Drug Modality Breakdown
On Market (3)
Approved therapies currently available
Competitive Landscape
49 companies ranked by most advanced pipeline stage
+19 more companies
Trial Timeline
Clinical trial activity over time
Showing 15 of 50 trials with date data
Clinical Trials (50)
Total enrollment: 20,384 patients across 50 trials
A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.
Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides
Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia
Rosuvastatin Effect on Atherosclerotic Plaque Metabolism
Long Term Safety Study of PRALUENT
Investigating the Effects of Lipid-therapy Intensification With Alirocumab on Endothelial Function, Carotid Arteries, Lipoprotein Particle Subfractions, Inflammation and Post-prandial Lipemia
Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg
Alirocumab in Patients With Acute Myocardial Infarction
Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia
Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo
Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)
Effect of Rosuvastatin Therapy on HDL2 Level
Effect of Rosuvastatin on Prognosis of Clinical Response in Acute Ischemic Stroke Patients(REPAIRS)
A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Treatment of the Carotid Atherosclerotic Plaques
LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients
Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease
The HDL Particle Protection Study
Rosuvastatin Effect on Serial Echocardiographic Measurement of Coronary Flow Velocity Reserve
A Study Comparing CoQ10 Levels While Taking 3 Different Statins
Intensive Statin Treatment for STEMI Patients Undergoing Primary PCI
Efficacy and Safety Study of Pitavastatin Versus Atorvastatin to Treat Hypercholesterolemia
Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH)
Korean AMADEUS Study
Effect of Crestor (Rosuvastatin) on Lipid Levels in Patients With Metabolic Syndrome
Atorvastatin Pre-Treatment Study In Asian Patients With Acute Coronary Syndrome
The Use of Statins for Myocardial Death Prevention
Bioequivalence Study Comparing A New 80 Mg Atorvastatin Tablet To A 80 Mg Atorvastatin Commercial Tablet
Bioequivalence Study Comparing A New 10 Mg Atorvastatin Tablet To A 10 Mg Atorvastatin Commercial Tablet
A Diabetes Study to Treat A Population Previously Not at Target
Safety and Efficacy Study of Pitavastatin in Patient With a Metabolic Syndrome
Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in Systemic Lupus Erythematosus (SLE) Patients With Corticosteroid Therapy and High Low-Density Lipoprotein (LDL) Cholesterol Level
Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases.
Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Type IIa and IIb Hypercholesterolaemic Patients
Virtual Histology Findings and Effects of Varying Doses of Atorvastatin Treatment
Statin Therapy for Ischemic and Nonischemic Cardiomyopathy
Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors
Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?
A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk
Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients
Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg
ROMEO (Rosuvastatin in Metabolic syndrOme)
Irbesartan in Chinese Hypertensive Diabetics With Microalbuminuria
I PREVENT - Irbesartan In Hypertensive Diabetic Patients
Effect of Short Term Atorvastatin Treatment,80mg/Day on Early Regression of Carotid Artery Atherosclerotic Lesions
Comparison of Ezetimibe Added to Ongoing Statin Therapy Versus Doubling the Dose of Statin in the Treatment of Hypercholesterolemia (P04355)
Efficacy and Safety of Colesevelam in Pediatric Patients With Genetic High Cholesterol
Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome
Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease
C-Reactive Protein (CRP) in Obese Diabetic Women
Related Jobs
Chronic Care Specialty Sales Representative - Lawrence/Kansas City
ED, Sr Marketing Strategist - Cardiovascular
Key Account Manager
Health Systems Medical Affairs Director - PA, NJ, DE
Alternance Accès au Marché – Prix et Remboursement H/F
Brand Engagement Manager, Cardiovascular
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.